Fenofibrate and Hepatojugular reflux - a phase IV clinical study of FDA data

Summary:

Hepatojugular reflux is reported as a side effect among people who take Fenofibrate (fenofibrate), especially for people who are male, 60+ old, also take Linagliptin, and have Acute kidney failure.

The phase IV clinical study analyzes which people have Hepatojugular reflux when taking Fenofibrate. It is created by eHealthMe based on reports of 39,402 people who have side effects when taking Fenofibrate from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Hepatojugular reflux?

Hepatojugular reflux (a venous reflux occurring in congestive heart failure) is found to be associated with 69 drugs and 114 conditions by eHealthMe. Check the latest studies of Hepatojugular reflux.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

39,402 people reported to have side effects when taking Fenofibrate.
Among them, 13 people (0.03%) have Hepatojugular reflux.

Could Fenofibrate cause Hepatojugular reflux?

Among these 13 people:

What is the gender of people who have Hepatojugular reflux when taking Fenofibrate? *

female: 0.0 %
male: 100 %

What is the age of people who have Hepatojugular reflux when taking Fenofibrate? *

What are other drugs people take besides Fenofibrate? *

What are other side effects people have besides Hepatojugular reflux? *

Weakness: 13 people, 100.00%
Diastolic Dysfunction: 13 people, 100.00%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 13 people, 100.00%
Fatigue (feeling of tiredness): 13 people, 100.00%
Fainting (loss of consciousness and postural tone): 13 people, 100.00%
Enlarged Heart: 13 people, 100.00%
Electrocardiogram Qt Prolonged: 13 people, 100.00%
Electrocardiogram Q Wave Abnormal: 13 people, 100.00%
Ejection Fraction Decreased (systolic heart failure): 13 people, 100.00%
Dyspnea At Rest: 13 people, 100.00%

What are the existing conditions these people have? *

High Blood Pressure: 13 people, 100.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 13 people, 100.00%
Cardiac Failure: 13 people, 100.00%
Acute Kidney Failure: 13 people, 100.00%
Carotid Arteriosclerosis (plaque deposition in artery): 12 people, 92.31%
Helicobacter Gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium): 8 people, 61.54%
Left Ventricular Failure (left ventricle fails to contract forcefully): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and have Hepatojugular reflux?

- Check whether Hepatojugular reflux is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fenofibrate:

Fenofibrate (40,457 reports)

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatojugular reflux:

Hepatojugular reflux (69 drugs)

Browse all the conditions that are associated with Hepatojugular reflux:

Hepatojugular reflux (114 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Fenofibrate) and Fenofibrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.